男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

中文USEUROPEAFRICAASIA

Bitter pill for traditional Chinese medicine in EU

By Zhang Chunyan in London ( China Daily ) Updated: 2013-11-25 01:48:30

New quality and safety rules may stifle sales prospects of TCM in the European market.

Bitter pill for traditional Chinese medicine in EU

Li Min/China Daily

In London's Chinatown, a poster in Chinese urges customers to stock up on traditional and other patent Chinese medicines before an impending ban on patented TCM products from next year.

At TCM clinics in London, patients still keep trickling in for acupuncture and massage services. However, there is a lull in demand for various Chinese herbal and patent medications because customers seem to be wary of the Medicines and Healthcare Products Regulatory Agency's forthcoming decision.

Therein lies the twist in the tale. Just as traditional Chinese medicine makes waves in the UK and the rest of Europe with alternative therapies such as acupuncture and massage, it finds itself being denied market access for medications.

Traditional Chinese medicine, which has evolved over 4,000 years, relies largely on patented and herbal medications to prevent and help the human body fight ailments, and treatments to relieve pain and restore balance in the body.

According to the proposal the MHRA floated on July 9, the sale of all unlicensed manufactured herbal medicinal products will be halted in the UK from next year. The MHRA is a British government agency that is responsible for ensuring that medicines and medical devices used in the UK are safe.

The proposal is not targeted specifically at TCM. Andrea Farmer, MHRA's herbal policy manager, says: "The decision was taken on the basis of the Traditional Herbal Medicinal Products Directive, incorporated by the EU in 2004, which stipulates that all the manufactured herbal medicines in the EU market should have a suitable product license."

The directive also introduced the so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to be licensed, including Chinese and Indian traditional medicines.

That period ended in April 2011. After that, the MHRA allowed products that were lawfully in the market before April 2011 to continue being sold, so retail businesses holding huge inventories were not unduly affected.

Although the regulator is yet to finalize its proposals and is still studying the various responses, TCM practitioners hope that a favorable decision will help rejuvenate it in Europe. But the real problem as most experts say is TCM's difficulties in getting licensed in the UK and Europe.

Not the right prescription for European regulators

Testing times ahead for Chinese medication

Needling away to gain big sway

Shenyang TCM exports hit $3m

China launches TCM census

Agency directs TCM production to ensure safety of consumers

Previous Page 1 2 3 4 Next Page

Most Popular
Special
...
...
主站蜘蛛池模板: 博湖县| 尉犁县| 宜宾县| 抚宁县| 浠水县| 华阴市| 邢台市| 汤原县| 宜川县| 吉木乃县| 锡林郭勒盟| 陕西省| 舞钢市| 舟山市| 阿拉善左旗| 鸡泽县| 璧山县| 东平县| 平山县| 大埔区| 子洲县| 资阳市| 林州市| 昌黎县| 廉江市| 彭泽县| 丰台区| 晴隆县| 梨树县| 天水市| 蒙自县| 界首市| 安国市| 寿光市| 乌什县| 大田县| 丰宁| 漳州市| 习水县| 兴城市| 桂林市|